Changes in basal insulin infusion rates with subcutaneous insulin infusion: Time until a change in metabolic effect is induced in patients with type 1 diabetes

Diabetes Care

Volumn 32, Issue 8, 2009, Pages 1437-1439

  Heinemann, Lutz ^a   Nosek, Leszek ^a   Kapitza, Christoph ^a   Schweitzer, Matthias Axel ^b   Krinelke, Lars ^c  

^a PROFIL Institut für Stoffwechselforschung   (Germany)

^b ROCHE DIAGNOSTICS GMBH   (Germany)

^c Disetronic Medical Systems AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HUMAN INSULIN; INSULIN LISPRO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INFUSION; HUMAN; INFUSION RATE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN PUMP; INSULINEMIA; MALE; OPEN STUDY; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; STEADY STATE;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; FATTY ACIDS, NONESTERIFIED; GLUCOSE CLAMP TECHNIQUE; HUMANS; INFUSION PUMPS, IMPLANTABLE; INFUSIONS, SUBCUTANEOUS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED;

EID: 68149089868     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc09-0595     Document Type: Article

References (8)

1. Hildebrandt P, Birch K, Jensen BM, Kühl C, Brange J. Absorption of subcutaneously infused insulin: influence of the basal rate pulse interval. Diabetes Care 1985;8:287-289 (Pubitemid 15071447)
2. Hildebrandt P, Birch K. Basal rate subcutaneous insulin infusion: absorption kinetics and relation to local blood flow. Diabet Med 1988;5:434-440 (Pubitemid 18174771)
3. Hildebrand P, Birch K, Jensen BM, Kühl C. Subcutaneous insulin infusion: change in basal infusion rate has no immediate effect on insulin absorption rate. Diabetes Care 1986;9:561-564 (Pubitemid 17208932)
4. Swan KL, Weinzimer SA, Dziura JD, Steil GM, Voskanyan GR, Steffen AT, Martin ML, Tamborlane WV. Effect of puberty on the pharmacodynamic and pharmacokinetic properties of insulin pump therapy in youth with type 1 diabetes. Diabetes Care 2008;31:44-46
5. Zisser H. Quantifying the impact of a short-interval interruption of insulin-pump infusion sets on glycemic excursions. Diabetes Care 2008;31:238-239 (Pubitemid 351213328)
6. Reichel A, Rietzsch H, Köhler HJ, Pfützner A, Gudat U, Schulze J. Cessation of insulin infusion at night-time during CSII-therapy: comparison of regular human insulin and insulin lispro. Exp Clin Endocrinol Diabetes 1998;106:168-172 (Pubitemid 28356606)
7. Buckingham B, Cobry E, Clinton P, Gage V, Caswell K, Kunselman E, Cameron F, Chase HP. Preventing hypoglycemia using predictive alarm algorithms and insulin pump suspension. Diabetes Technol Ther. 2009;11:93-97
8. Klinkert C, Bachran R, Heidtmann B, Grabert M, Holl RW; DPV-Initiative. Age-specific characteristics of the basal insulinrate for pediatric patients on CSII. Exp Clin Endocrinol Diabetes 2008;116:118-122